SciELO - Scientific Electronic Library Online

 
vol.53 suppl.4Sistema de Protección Social en Salud y calidad de la atención de hipertensión arterial y diabetes mellitus en centros de saludAnálisis cualitativo del abasto de medicamentos en México: evaluación en los servicios a población no asegurada índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay artículos similaresSimilares en SciELO

Compartir


Salud Pública de México

versión impresa ISSN 0036-3634

Resumen

LOPEZ-MORENO, Sergio et al. Organization of the drug supply chain in state health services: potential consequences of the public-private mix.. Salud pública Méx [online]. 2011, vol.53, suppl.4, pp.445-457. ISSN 0036-3634.

OBJECTIVE. To assess the consequences of private outsourcing on the overall supply and filling of prescriptions in state health services. MATERIAL AND METHODS. The research was conducted using quantitative and qualitative techniques in 13 states. The information was collected through interviews and direct observation. The interviews were carried on staff of state health services related to the drug supply chain and users of health services. The quantitative approach examined the percentage of stocked full recipes in a sample of users. RESULTS States that have opted for the fully outsourced model, and properly monitored this choice, have increased the supply of drugs to their users and guaranteed the supply in the care units in charge. Other states with the outsourced model have multiple problems: direct purchase of drugs not included in the basic drugs catalogue, failure of suppliers and shortage of supplies in the laboratories that provide the company. The main disadvantages identified in all models were: the subordination of the medical criteria to administrative criteria, insufficient planning based on local care needs, heterogeneous procedures, insufficient knowledge of regulations and lack of normativity. CONCLUSION. The results indicate that the incorporation of private providers in the drug supply chain may not be the solution to bring down the shortage faced by health services, especially at the hospital level. The shift to outsourcing models has developed without incorporating evaluation mechanisms and the consequences that this transition can have on state health systems must be investigated more deeply.

Palabras llave : supply chain management; drugs prescription; Mexico.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons